BULIS VERONICA SANCHEZ (VP, Corporate Controller) sold 1.4% of their position (217.00 shares) of LYELL IMMUNOPHARMA, INC. on the open market
Open‑market sale worth $4.1K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 6/15/2026ACC: 0002095702-26-000004
Officer· VP, Corporate Controller
Since Feb 2026
-217.00
Net shares
Net seller
$4.1K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
217.00 disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−217.00
Price / share
$18.91
Trade value
$4.10K
% of position
1.4%
5/11/2026
15.64K→15.42K
Total
Net shares
−217.00
Net value
-$4.10K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 5/11/2026 | S · Sale | −217.00 | $18.91 | $4.10K | 1.4% | 15.64K | 15.42K |
| Total | −217.00 | -$4.10K | ||||||
Derivative Transactions0
No derivative transactions reported